BioSpace News Archive

Bio-Techne Corporation announced that the B-MoGen Biotechnologies portfolio of genome engineering services, GMP therapeutic manufacturing services, and its proprietary transposon-transposase gene transfer system, TcBuster™, will be rebranded as R&D Systems.

Leap Therapeutics, Inc. and BeiGene, Ltd. announced that the first patient has been dosed in the DisTinGuish study, a Phase 2a clinical trial evaluating Leap’s investigational anti-Dickkopf-1 antibody, DKN-01, in combination with tislelizumab, BeiGene’s anti-PD-1 antibody, with or without chemotherapy, in patients with gastric or gastroesophageal junction cancer.

Sutro Biopharma, Inc., a clinical-stage drug discovery, development and manufacturing company announced that it has been recognized as Best New Drug Developer at the World ADC Digital Awards, held during the World ADC Digital Event.

ESSA Pharma Inc., a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer announced the Company will be presenting at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd at 11:40am Eastern.

BioVie Inc., a clinical-stage company developing innovative drug therapies for liver disease, announced that Jonathan Adams, the Company’s President & COO, will present at the Oppenheimer Fall Healthcare Life Sciences & Medtech Summit on Monday, September 21, 2020 at 1:40 p.m. ET.

Algiax Pharmaceuticals, a clinical-stage biotechnology company focused on development of GABAA receptor modulators for neuropathic pain and other indications with unmet medical need, announced that the first patient has been enrolled in the “CURE” study.

A fungal infection is also known as mycosis. It is a skin disease caused by a fungus. There are a million species of fungi.

EASD, the leading European association in the field of diabetes, has selected the positive results of the international Phase II clinical study on TOTUM-63 in prediabetes to be presented next September in its 56th annual meeting. These results were selected by the American Diabetes Association last June 2020.

Diabetic dogs and cats can live long and healthy lives with proper management and veterinary care.

Multi-year strategic collaboration in target discovery and therapeutic development based on Scenic Biotech’s disease modifying approach